PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS

A compound having the structure:or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein A, A', A", R0, R, R1, R2, X, R4, and R5, are as defined in the description, for therapeutic use, wherein whe...

Full description

Saved in:
Bibliographic Details
Main Authors GERSTENBERGER, BRIAN, STEPHEN, XING, LI, HUANG, DERMENCI, ALPAY, YANG, XIAOJING, HAYWARD, MATTHEW, MERRILL, FENSOME, ANDREW, OWEN, DAFYDD, RHYS, WRIGHT, STEPHEN, WAYNE, BROWN, MATTHEW, FRANK
Format Patent
LanguageEnglish
Serbian
Published 30.06.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A compound having the structure:or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein A, A', A", R0, R, R1, R2, X, R4, and R5, are as defined in the description, for therapeutic use, wherein where the compound, or the pharmaceutically acceptable salt thereof, or the pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, is administered orally.
Bibliography:Application Number: RS2020P000584